Cite
An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db/db mice.
MLA
Lu, Weisheng, et al. “An Orally Available Hypoglycaemic Peptide Taken up by Caveolae Transcytosis Displays Improved Hypoglycaemic Effects and Body Weight Control in Db/Db Mice.” British Journal of Pharmacology, vol. 177, no. 15, Aug. 2020, pp. 3473–88. EBSCOhost, https://doi.org/10.1111/bph.15069.
APA
Lu, W., Tian, H., Qian, P., Li, Y., Wang, Y., Ge, Y., Sai, W., Gao, X., & Yao, W. (2020). An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db/db mice. British Journal of Pharmacology, 177(15), 3473–3488. https://doi.org/10.1111/bph.15069
Chicago
Lu, Weisheng, Hong Tian, Peng Qian, Ying Li, Yongkang Wang, Yang Ge, Wenbo Sai, Xiangdong Gao, and Wenbing Yao. 2020. “An Orally Available Hypoglycaemic Peptide Taken up by Caveolae Transcytosis Displays Improved Hypoglycaemic Effects and Body Weight Control in Db/Db Mice.” British Journal of Pharmacology 177 (15): 3473–88. doi:10.1111/bph.15069.